Article
Effect of genetically proxied use of PDE5 inhibitors on risk of CHD: A drug target Mendelian Randomization study
2024-10-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background and aim</bold> There have been previous and recent studies generating conflicting findings on effect of phosphodiesterase 5 (PDE5) inhibitors with CHD, Diabetes, breast cancer and prostatic cancer. Since we intended to use naturally occurring variation in genes encoding PDE5 to investigate association between genetically proxied PDE5 inhibitors and them. <bold>Method</b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e168a5cc-45d3-51d6-b533-9f25bfb811b2
- DOI
- 10.21203/rs.3.rs-5236402/v1
